- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00196443
The Influence of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Disease
September 12, 2005 updated by: University Medicine Greifswald
Prospective, Randomized and Explorative Controlled Study About Influences of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Insufficiency
The purpose of this study is to investigate if wearing of compression stockings influences the skin moisture.
Conservative stockings are compared with urea containing compression stockings to find out if using urea prevents dehydration of the skin while wearing the urea compression stockings.
Secondary aim was to find out if urea containing stockings increase the compliance to wear the compression stockings regulary by patients with diagnosed chronic venous insufficiency.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
42
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fleischmannstr. 42-44
-
Greifswald, Fleischmannstr. 42-44, Germany, 17475
- Clinic and Polyclinic of Dermatology, Ernst-Moritz-Arndt-University of Greifswald
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clincial diagnosis of chronic venous insufficiency
- Age: 18-80 years
- Patient's information and willingness to participate
Exclusion Criteria:
- Age under 18 years
- Lower limp edema not caused by venous insufficiency
- Acute deep venous thrombosis
- Arterial occlusive disease
- Diabetes mellitus with neuropathy or peripheral arterial disturbance of perfusion
- immobile Patients
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
skin moisture at day 0 and day 7
|
|
loss of water throughout epidermis at day 0 and day 7
|
|
throatiness of epidermis at day 0 and day 7
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
compliance of patients at every day of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Jünger, Prof. Dr., Clinic and Polyclinic of Dermatology, University of Greifswald
- Study Chair: Andrea Ladwig, Clinic and Polyclinic of Dermatology, University of Greifswald
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Completion
July 1, 2005
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 20, 2005
Study Record Updates
Last Update Posted (Estimate)
September 20, 2005
Last Update Submitted That Met QC Criteria
September 12, 2005
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Bau-Phleb-17032005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.